Dr. Urban Kiernan, the company's Founder & CEO, takes a moment to introduce iMBP and the growing threat of obesity related disease.
iMetabolic Biopharma Corporation quickly narrates the profound extend that obesity and its related diseases have penetrated into American society and the economic challenge it is creating.
News release regarding the growth of obesity and resultant proliferation of non-alcoholic fatty liver disease (NAFLD) in the pediatric population.
Dr. Urban Kiernan highlights the number of different diseases that cluster in patients with obesity.
Dr. Urban Kiernan touches on the associated costs related to the treatment of several obesity related diseases.
Dr. Urban Kiernan discusses COVID-19 and how iMBP is part of the long term solution.
Dr. Kiernan shares some factual insight on the impact that metabolic disease and obesity have on COVID 19.